These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15719581)

  • 1. Direct thrombin inhibitors in heparin-induced thrombocytopenia.
    Verme-Gibboney C; Dubb JW
    Am J Health Syst Pharm; 2005 Feb; 62(3):247-8; author reply 248, 250. PubMed ID: 15719581
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
    Matsuo T; Kario K; Chikahira Y; Nakao K; Yamada T
    Br J Haematol; 1992 Nov; 82(3):627-9. PubMed ID: 1486048
    [No Abstract]   [Full Text] [Related]  

  • 3. Argatroban approved for heparin-induced thrombocytopenia.
    Miller JL
    Am J Health Syst Pharm; 2000 Sep; 57(18):1650. PubMed ID: 11006790
    [No Abstract]   [Full Text] [Related]  

  • 4. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM; Wittkowsky AK; Wiggins BS
    Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argatroban.
    McKeage K; Plosker GL
    Drugs; 2001; 61(4):515-22; discussion 523-4. PubMed ID: 11324681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Jul; 373(3):252-61. PubMed ID: 26176382
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
    Gilmore JF; Adams CD; Blum RM; Fanikos J; Anne Hirning B; Matta L
    Am J Hematol; 2015 Aug; 90(8):E143-5. PubMed ID: 25913754
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
    Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
    Matsuo T; Kario K; Kodama K; Okamoto S
    Semin Thromb Hemost; 1992; 18(2):155-60. PubMed ID: 1631564
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.
    Quiñones-Ortiz L; Suárez-Laurés A; Pablos-de Pablo M; Robles V; Calzón-Blanco C; Quiñones-Pérez S; Ayausty-Ruiz A
    Nefrologia; 2014; 34(5):670-4. PubMed ID: 25036261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-Induced Thrombocytopenia.
    Hoover J
    N Engl J Med; 2015 Nov; 373(19):1883. PubMed ID: 26535527
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin-Induced Thrombocytopenia.
    Klarenbeek NB; Eikenboom JC
    N Engl J Med; 2015 Nov; 373(19):1882-3. PubMed ID: 26535526
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Nov; 373(19):1883-4. PubMed ID: 26535525
    [No Abstract]   [Full Text] [Related]  

  • 20. INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.
    Raaz U; Maegdefessel L; Buerke M; Janusch M; Werdan K; Schlitt A
    Thromb Res; 2009 Jun; 124(2):242-3. PubMed ID: 19019411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.